0001209191-23-053510.txt : 20231024 0001209191-23-053510.hdr.sgml : 20231024 20231024194654 ACCESSION NUMBER: 0001209191-23-053510 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231023 FILED AS OF DATE: 20231024 DATE AS OF CHANGE: 20231024 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Benatti Luca CENTRAL INDEX KEY: 0001613842 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38890 FILM NUMBER: 231343688 BUSINESS ADDRESS: STREET 1: C/O INTERCEPT PHARMACEUTICALS, INC. STREET 2: 450 WEST 15TH STREET, SUITE 505 CITY: NEW YORK STATE: NY ZIP: 10011 BUSINESS PHONE: 646-747-1000 MAIL ADDRESS: STREET 1: C/O INTERCEPT PHARMACEUTICALS, INC. STREET 2: 450 WEST 15TH STREET, SUITE 505 CITY: NEW YORK STATE: NY ZIP: 10011 FORMER NAME: FORMER CONFORMED NAME: Luca Benatti DATE OF NAME CHANGE: 20140715 FORMER NAME: FORMER CONFORMED NAME: Luca Benatti c/o Intercept Pharmaceuticals, Inc DATE OF NAME CHANGE: 20140715 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Quince Therapeutics, Inc. CENTRAL INDEX KEY: 0001662774 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 901024039 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 601 GATEWAY BOULEVARD, SUITE 1250 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-910-5717 MAIL ADDRESS: STREET 1: 601 GATEWAY BOULEVARD, SUITE 1250 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: Cortexyme, Inc. DATE OF NAME CHANGE: 20160104 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-10-23 0 0001662774 Quince Therapeutics, Inc. QNCX 0001613842 Benatti Luca C/O QUINCE THERAPEUTICS, INC. 601 GATEWAY BLVD, SUITE 1250 SOUTH SAN FRANCISCO CA 94080 1 0 0 0 0 Employee Stock Option (right to buy) 0.99 2023-10-23 4 A 0 54000 0.00 A 2033-10-22 Common Stock 54000 54000 D The shares subject to the stock option shall vest in equal annual installments over the three-year period following the grant date of October 23, 2023, subject to the Reporting Person's continued service as a member of the Board of Directors of the Issuer as of each such vesting date. /s/ Brendan Hannah, Attorney-in-Fact for Luca Benatti 2023-10-24